INNO:CSE, InnoCan Pharma Corporation

INNO stock overview

InnoCan Pharma Corporation (INNO:CSE) closed at $1.90 on October 15, 2026, unchanged on the day. The stock trades 90.1% below its 52-week high of $19.15 and 18.8% above its 52-week low of $1.60. Over the past year, it lost 88.8%. InnoCan Pharma Corporation is part of the Life Sciences sector.

Key figures

Price
$1.90
Day change
0.00%
Volume
0
Average volume
1,769
Market cap
8M+
52-week range
$1.60 – $19.15
50-day average
$2.16
200-day average
$4.50

Price action over the past year

In 252 trading sessions since October 24, 2025, INNO closed higher on 49 days (19%). Its best day was July 3, 2026 (+45.83%) and its worst was July 28, 2026 (-26.10%). The stock moved 10% or more in a single session 32 times. It opened at least 5% above the previous day's high 14 times.

Recent signals

INNO news

About InnoCan Pharma Corporation

InnoCan Pharma Corp is a Canada based company engaged in the research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products. Its brands include Shir and Relief & Go.

Similar stocks

Find more stocks like INNO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.